Livazo coated tablets 4mg №28

Use Livazo is indicated for reducing elevated total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) in adults, adolescents, and children aged 6 years and older with primary hypercholesterolemia, including heterozygous familial hypercholesterolemia (Fredrickson type IIa hyperlipidemia), or mixed hypercholesterolemia (Fredrickson type IIb hyperlipidemia), as well as hypertriglyceridemia (Fredrickson type IV hyperlipidemia) as an adjunct to diet, when diet and other non-pharmacological treatments (e.g., exercise, weight reduction) are insufficient. How to take The initial dose is generally 1 mg per day. The maximum daily dose is 4 mg, and for patients with renal and hepatic insufficiency, it should not exceed 2 mg. It is preferable to take the tablet at the same time of day, preferably in the evening, in accordance with the circadian rhythm of lipid metabolism. Contraindications - Hypersensitivity to pitavastatin, excipients of the drug, and other HMG-CoA reductase inhibitors (statins). - Severe hepatic insufficiency (Child-Pugh score > 9) or Child-Pugh class C, active liver disease, including persistent elevation of serum transaminases (more than 3 times the upper limit of normal). - Myopathy. - Concomitant use of cyclosporine. - Pregnancy, breastfeeding, lack of adequate contraception in women of childbearing age. - Age under 18 years (efficacy and safety not established). Storage Store in a light-protected, out of reach of children place, at a temperature not exceeding 25 degreeC.